Heather Zacker, MS, senior director of Care Alliances of Joslin Innovation at Joslin Diabetes Center, discussed several ways primary care offices can transform their practices to provide optimal diabetes care. These include quality improvement, data analysis, and benchmarking initiatives to make the office more diabetes-friendly.
Heather Zacker, MS, senior director of Care Alliances of Joslin Innovation at Joslin Diabetes Center, discussed several ways primary care offices can transform their practices to provide optimal diabetes care. These include quality improvement, data analysis, and benchmarking initiatives to make the office more diabetes-friendly.
Transcript (slightly modified)
What is the importance of the primary care provider when caring for patients with diabetes?
85 to 90% of people with diabetes are cared for in the primary care setting, as opposed to an endocrinologist’s office, and that’s people who are diagnosed with diabetes. Clearly, the primary care provider is the person with the most influence, the clinician with the most influence on how the patient manages his or her diabetes. Yet, primary care physicians have to be masters of, or experts in, so many different conditions and diseases, and it’s really not something that’s easy to do.
One of the things we’ve done at the Joslin Diabetes Center, where I direct our Care Alliances program, is develop initiatives to certify primary care physicians in diabetes. What we do is look at the data, do a chart audit of a subset of their patients with diabetes, and try to understand where would there be opportunities to advance treatment further. Where are somebody on one agent where they should be on a second oral agent, or advanced insulin sooner, or something like that.
Then try to bring that data to show the PCPs and show them benchmarked, how they’re doing compared to others, because doctors can often tend to be a competitive bunch and that can be a useful tool. Then do an assessment of the office, take a look at the office staff, at the office systems, find ways that we can put QI projects, quality improvement projects in place. Create a sense of ownership among everyone from the medical assistants to the nurses, et cetera, and through that mechanism really make the practice a diabetes-friendly practice.
So we did a couple of programs like this over the years through Joslin in collaboration with sponsorships from some industry leaders. We did one maybe about 8 or 9 years ago where we trained something like 1600 primary care physicians, half in New York City and half in Detroit. We did very many of the things I was just describing, and we tracked A1Cs, patient knowledge, optimism, empowerment, all those kinds of things, and they all went in the direction that you would want them to go in. So how could you roll something like that out on a large scale basis, I think that’s really the challenge.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
2 Commerce Drive
Cranbury, NJ 08512